Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of Various antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 939-941

  Souli, Maria ^a,c   Giamarellou, Helen ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFPIROME; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; ISEPAMICIN; NETILMICIN; OFLOXACIN; PEFLOXACIN; RIFAMPICIN; ROXITHROMYCIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG PENETRATION; IMPLANT; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SURGICAL PATIENT;

EID: 0031955906     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.939     Document Type: Article

References (31)

1. Anwar, H., J. L. Strap, and J. W. Costerton. 1992. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 36:1347-1351.
2. Brown, M. R. W., R. E. Courcol, S. Gander, and P. Gilbert. 1994. Influence of growth rate on susceptibility of biofilm-grown Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli to ciprofloxacin, p. 296-297. In J. Einhorn, C. E. Nord, and S. R. Norby (ed.), Recent advances in chemotherapy. American Society for Microbiology, Washington, D.C.
3. Brown, M. R. W., and P. Gilbert. 1993. Sensitivity of biofilms to antimicrobial agents. J. Appl. Bacteriol. 74(Suppl. 1):S87-S97.
4. Christensen, G. D., W. A. Simpson, A. L. Bisno, and E. H. Beachey. 1982. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. 37:318-326.
5. Costerton, J. W., B. Ellis, K. Lam, F. Johnson, and A. E. Khoury. 1994. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicroh. Agents Chemother. 38:2803-2809.
6. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
7. Darouiche, R. O., A. Dhir, A. J. Miller, G. C. Landon, I. I. Raad, and D. M. Musher. 1994. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J. Infect. Dis. 170:720-723.
8. Drancourt, M., A. Stein, J. N. Argenson, A. Zannier, G. Curvale, and D. Raoult. 1993. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 37:1214-1218.
9. Dunne, W. M., E. O. Mason, and S. L. Kaplan. 1993. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 37:2522-2526.
10. Evans, R. C., and C. J. Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894.
11. Farber, B. F., M. H. Kaplan, and A. G. Glogston. 1990. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J. Infect. Dis. 161:37-40.
12. Gander, S. 1996. Bacterial biofilms: resistance to antimicrobial agents. J. Antimicrob. Chemother. 37:1047-1050.
13. Giamarellou, H., M. Souli, and M. Papapetropoulou. 1991. Diffusion of various antibiotics through slime produced by clinical isolates of coagulase-negative staphylococci (CNS), abstr. 1310, p. 317. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Graninger, W., C. Wenisch, and M. Hasenhundl. 1995. Treatment of staphylococcal infections. Curr. Opin. Infect. Dis. 8(Suppl. 1):20-28.
15. Gray, E. D., W. E. Regelmann, and G. Peters. 1987. Staphylococcal slime and host defences: effects on lymphocytes and immune function, p. 45-54. In G. Pulverer, P. G. Quie, and G. Peters (ed.), Pathogenicity and clinical significance of coagulase-negative staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
16. Hoyle, B. D., J. Alcantara, and J. W. Costerton. 1992. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob. Agents Chemother. 36:2054-2056.
17. Kloos, W. E., and T. L. Bannerman. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117-140.
18. Kumon, H., K. Tomochika, T. Matunaga, M. Ogawa, and H. Ohmori. 1994. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas aeruginosa exopolysaccharides. Microbiol. Immunol. 38:615-619.
19. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. I. Walmsley. 1988. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 32:1518-1523.
20. Peters, G., C. von Eiff, and M. Herrmann. 1995. The changing pattern of coagulase-negative staphylococci as infectious pathogens. Curr. Opin. Infect. Dis. 8(Suppl. 1):12-19.
21. Richards, G. K., R. F. Gagnon, and R. J. Morcos. 1994. An assay to measure antibiotic efficacy against Staphylococcus epidermidis biofilms on implant surfaces. ASAIO J. 40:M570-M575.
22. Rupp, M. E., and G. D. Archer. 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19:231-245.
23. Shigeta, M., H. Komatsuzawa, M. Sugai, H. Suginaka, and T. Usui. 1997. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents. Chemotherapy 43:137-141.
24. Stewart, P. S. 1996. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40:2517-2522.
25. Stoodley, P., D. DeBeer, and H. M. Lappin-Scott. 1997. Influence of electric fields and pH on biofilm structure as related to the bioelectric effect. Antimicrob. Agents Chemother. 41:1876-1879.
26. Stout, E. D., K. P. Ferguson, Y. Li, and D. W. Lambe. 1992. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun. 60:922-927.
27. Wellman, N., S. M. Fortun, and B. R. McLeod. 1996. Bacterial biofilms and the bioelectric effect. Antimicrob. Agents Chemother. 40:2012-2014.
28. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102.
29. Younger, J. J., G. D. Christensen, D. L. Bartley, J. C. Simmons, and F. F. Barrett. 1987. Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification and shunt removal to clinical outcome. J. Infect. Dis. 156:548-554.
30. Ziebuhr, W., C. Heilmann, F. Gotz, P. Meyer, K. Wilms, E. Straube, and J. Hacker. 1997. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65:890-896.
31. Ziscovici, S., and V. Lorian. 1989. Slime from Staphylococcus epidermidis interrupts antibiotic diffusion, abstr. 216, p. 128. In Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.